Back

High KIR diversity in Uganda and Botswana children living with HIV

John, M.; Kyobe, S.; Amujal, M.; Katagirya, E.; Diphoko, T.; Sebetso, G.; Mwesigwa, S.; Mboowa, G.; Retshabile, G.; Williams, L.; Mogomotsi, M.; Mlotshwa, B.; Jjingo, D.; kateete, D. P.; Joloba, M.; Mardon, G.; Hanchard, N.; Hollenbach, J. A.

2024-12-07 genomics
10.1101/2024.12.03.626612 bioRxiv
Show abstract

Killer-cell immunoglobulin-like receptors (KIRs) are essential components of the innate immune system found on the surfaces of natural killer (NK) cells. The KIRs encoding genes are located on chromosome 19q13.4 and are genetically diverse across populations. KIRs are associated with various disease states including HIV progression, and are linked to transplantation rejection and reproductive success. However, there is limited knowledge on the diversity of KIRs from Uganda and Botswana HIV-infected paediatric cohorts, with high endemic HIV rates. We used next-generation sequencing technologies on 312 (246 Uganda, 66 Botswana) samples to generate KIR allele data and employed customised bioinformatics techniques for allelic, allotype and disease association analysis. We show that these sample sets from Botswana and Uganda have different KIRs of different diversities. In Uganda, we observed 147 vs 111 alleles in the Botswana cohort, which had a more than 1 % frequency. We also found significant deviation towards homozygosity for the KIR3DL2 gene for both rapid (RPs) and long-term non-progressors (LTNPs)in the Ugandan cohort. The frequency of the bw4-80I ligand was also significantly higher among the LTNPs than RPs (8.9 % Vs 2.0%, P-value: 0.032). In the Ugandan cohort, KIR2DS4*001 (OR: 0.671, 95 % CI: 0.481-0.937, FDR adjusted Pc=0.142) and KIR2DS4*006 (OR: 2.519, 95 % CI: 1.085-5.851, FDR adjusted Pc=0.142) were not associated with HIV disease progression after adjustment for multiple testing. Our study results provide additional knowledge of the genetic diversity of KIRs in African populations and provide evidence that will inform future immunogenetics studies concerning human disease susceptibility, evolution and host immune responses.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3102 papers in training set
Top 6%
10.2%
2
Frontiers in Immunology
586 papers in training set
Top 1%
6.4%
3
eLife
5422 papers in training set
Top 13%
6.4%
4
International Journal of Infectious Diseases
126 papers in training set
Top 0.2%
6.4%
5
Viruses
318 papers in training set
Top 1%
4.9%
6
PLOS ONE
4510 papers in training set
Top 31%
4.9%
7
PLOS Pathogens
721 papers in training set
Top 3%
4.4%
8
Journal of Virology
456 papers in training set
Top 1%
4.2%
9
Genes & Immunity
11 papers in training set
Top 0.1%
4.2%
50% of probability mass above
10
Virus Evolution
140 papers in training set
Top 0.5%
2.8%
11
The Journal of Infectious Diseases
182 papers in training set
Top 2%
2.5%
12
Frontiers in Genetics
197 papers in training set
Top 3%
2.1%
13
Molecular Biology and Evolution
488 papers in training set
Top 2%
1.9%
14
iScience
1063 papers in training set
Top 13%
1.8%
15
Genetics
225 papers in training set
Top 2%
1.7%
16
PLOS Computational Biology
1633 papers in training set
Top 16%
1.7%
17
The Journal of Immunology
146 papers in training set
Top 1.0%
1.5%
18
PLOS Genetics
756 papers in training set
Top 10%
1.3%
19
Cell Reports
1338 papers in training set
Top 27%
1.3%
20
Communications Biology
886 papers in training set
Top 12%
1.3%
21
Nature Communications
4913 papers in training set
Top 56%
1.2%
22
BMC Genomics
328 papers in training set
Top 4%
1.1%
23
PLOS Medicine
98 papers in training set
Top 4%
0.9%
24
Cell Genomics
162 papers in training set
Top 5%
0.9%
25
Human Molecular Genetics
130 papers in training set
Top 3%
0.8%
26
Genome Medicine
154 papers in training set
Top 8%
0.7%
27
mBio
750 papers in training set
Top 12%
0.7%
28
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 6%
0.7%
29
AIDS
31 papers in training set
Top 0.5%
0.7%
30
F1000Research
79 papers in training set
Top 6%
0.7%